Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-18
DOI
10.1007/s40256-022-00551-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation
- (2022) Linh Ngo et al. European Heart Journal-Quality of Care and Clinical Outcomes
- Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
- (2022) Harry J.G.M. Crijns et al. Circulation-Arrhythmia and Electrophysiology
- Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study
- (2022) Linh Ngo et al. European Heart Journal-Quality of Care and Clinical Outcomes
- Flecainide-induced QRS complex widening correlates with negative inotropy
- (2021) Ana B. Rabêlo Evangelista et al. HEART RHYTHM
- Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
- (2021) Md Abdur Rashid et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion
- (2021) Douglas Darden et al. JAMA Cardiology
- Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
- (2020) Richard L. Verrier et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Three Novel Prevention, Diagnostic and Treatment Options for COVID-19 Urgently Necessitating Controlled Randomized Trials
- (2020) Richard I. Horowitz et al. MEDICAL HYPOTHESES
- Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy
- (2020) Stanley Nattel et al. CIRCULATION RESEARCH
- Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
- (2020) Jia Wu et al. Frontiers in Medicine
- Development and characterization of meropenem dry powder inhaler formulation for pulmonary drug delivery
- (2020) Saiqa Muneer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Non-vitamin K antagonist oral anticoagulants and factors influencing the ischaemic and bleeding risk in elderly patients with atrial fibrillation
- (2020) Giuseppe Patti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
- (2019) Noel C. Chan et al. BLOOD
- Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis
- (2019) Aateka Patel et al. Pharmaceutics
- Pulmonary Delivery of Metoprolol Reduces Ventricular Rate during Atrial Fibrillation and Accelerates Conversion to Sinus Rhythm
- (2019) Alexandre A. Marum et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation
- (2019) Fernanda Tessarolo Silva et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Translational Challenges in Atrial Fibrillation
- (2018) Jordi Heijman et al. CIRCULATION RESEARCH
- Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD
- (2018) Janis K Shute et al. CURRENT OPINION IN PHARMACOLOGY
- Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model
- (2018) Richard L. Verrier et al. HEART RHYTHM
- Comparative Pharmacokinetic and Electrocardiographic Effects of Intratracheal and Intravenous Administration of Flecainide in Anesthetized Pigs
- (2018) Fernando G. Stocco et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inhalation of peptide-loaded nanoparticles improves heart failure
- (2018) Michele Miragoli et al. Science Translational Medicine
- Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration
- (2018) Alexandre A. Marum et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pulmonary delivery of flecainide causes a rate-dependent predominant effect on atrial compared with ventricular depolarization duration revealed by intracardiac recordings in an intact porcine model
- (2018) Victor Z. de Antonio et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Inhaled Heparin: Therapeutic Efficacy and Recent Formulations
- (2017) Ayca Yildiz-Pekoz et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- The future of atrial fibrillation management: integrated care and stratified therapy
- (2017) Paulus Kirchhof LANCET
- Therapeutic Prospects of Gene Therapy for Atrial Fibrillation
- (2016) Melad Farraha et al. Heart Lung and Circulation
- Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?
- (2016) Hiran Bandeshe et al. JOURNAL OF CRITICAL CARE
- Atrial fibrillation: review of current treatment strategies
- (2016) Joshua Xu et al. Journal of Thoracic Disease
- Inhaled Anticoagulation Regimens for the Treatment of Smoke Inhalation–Associated Acute Lung Injury
- (2013) Andrew C. Miller et al. CRITICAL CARE MEDICINE
- Catheter Ablation for Persistent Atrial Fibrillation
- (2012) Laurent Roten et al. Circulation-Arrhythmia and Electrophysiology
- Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model
- (2011) Olympia Bikou et al. CARDIOVASCULAR RESEARCH
- Atrial Fibrillation Pathophysiology
- (2011) Yu-ki Iwasaki et al. CIRCULATION
- Challenges in inhaled product development and opportunities for open innovation
- (2010) Ben Forbes et al. ADVANCED DRUG DELIVERY REVIEWS
- Inhalable Lactose-Based Dry Powder Formulations of Low Molecular Weight Heparin
- (2009) Shuhua Bai et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Dry powder inhalers (DPIs)—A review of device reliability and innovation
- (2008) Nazrul Islam et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation
- (2008) Amit Rawat et al. JOURNAL OF CONTROLLED RELEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now